<table id="id_a2fb7e42-29c9-402a-bc3c-f3101b31450d" width="0.000" xmlns="urn:hl7-org:v3" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
<caption id="id_3aa35226-b5f0-47c4-bcbe-ff0faacdf264">Table 1: RELATIVE AND ABSOLUTE RISK SEEN IN THE CE/MPA SUBSTUDY OF WHI<footnote id="id-d5927b10-f078-4354-b174-9dc1502fba37">adapted from JAMA, 2002; 288:321-333<br/>
</footnote>
</caption>
<col></col>
<col></col>
<col></col>
<col></col>
<tbody>
<tr id="id_261829ea-7c17-4027-aa8d-ae03334cdb75" stylecode="Toprule">
<td align="left" valign="top">Event <footnote id="id-4c341f78-1dee-4e43-945e-eed8f00c090e">a subset of the events was combined in a “global index”, defined as the earliest occurrence of CHD events, invasive breast cancer, stroke, pulmonary embolism, endometrial cancer, colorectal cancer, hip fracture, or death due to other causes<br/>
</footnote>
</td>
<td align="left" stylecode="Toprule" valign="top">
<paragraph>Relative Risk <br/>CE/MPA vs placebo<br/> at 5.2 Years</paragraph>(95% CI<footnote id="id-5cecc544-4848-4eb2-92f4-b48fce9a460c">nominal confidence intervals unadjusted for multiple looks and multiple comparisons</footnote>)</td>
<td align="left" stylecode="Toprule" valign="top">Placebo<br/>n = 8102</td>
<td align="left" valign="top">
<paragraph>CE/MPA</paragraph>n = 8506</td>
</tr>
<tr id="id_3b9234ac-788b-406a-99e9-5741c2c4742e">
<td align="left" valign="top"></td>
<td align="left" valign="top"></td>
<td align="left" colspan="2" valign="top">
<paragraph>Absolute Risk per 10,000 Women-years</paragraph>
</td>
</tr>
<tr id="id_41a7a7de-2388-442d-a9e7-c4132c893c26">
<td align="left" valign="top">CHD events<br/>
<content stylecode="italics">Non-fatal MI<br/> CHD death</content>
</td>
<td align="center" valign="middle">1.29 (1.02 to 1.63)<br/>
<content stylecode="italics">1.32 (1.02 to 1.72)<br/>1.18 (0.70 to 1.97)</content>
</td>
<td align="center" valign="middle">30<br/>23<br/>6</td>
<td align="center" valign="middle">37<br/>
<content stylecode="italics">30<br/>7</content>
</td>
</tr>
<tr id="id_a5dee9fb-44b7-4c43-9cc3-0428d3a6fb3b">
<td align="left" valign="top">Invasive breast cancer<footnote id="id-38f02e60-e951-4957-8b75-bbe77bc4cad4">includes metastatic and non-metastatic breast cancer with the exception of in situ breast cancer<br/>
</footnote>
</td>
<td align="center" valign="middle">1.26 (1.00 to 1.59)</td>
<td align="center" valign="middle">30</td>
<td align="center" valign="middle">38</td>
</tr>
<tr id="id_05d9b273-956d-4bc3-8a3b-03480f9524dc">
<td align="left" valign="top">Stroke</td>
<td align="center" valign="middle">1.41 (1.07 to 1.85)</td>
<td align="center" valign="middle">21</td>
<td align="center" valign="middle">29</td>
</tr>
<tr id="id_8f6e28f1-942c-452c-a617-c35cbf4bc825">
<td align="left" valign="top">Pulmonary embolism</td>
<td align="center" valign="middle">2.13 (1.39 to 3.25)</td>
<td align="center" valign="middle">8</td>
<td align="center" valign="middle">16</td>
</tr>
<tr id="id_3cc0a75c-53f2-4bda-b3dc-8734ea235bb5">
<td align="left" valign="top">Colorectal cancer</td>
<td align="center" valign="middle">0.63 (0.43 to 0.92)</td>
<td align="center" valign="middle">16</td>
<td align="center" valign="middle">10</td>
</tr>
<tr id="id_493f16dc-bbb2-4e57-b442-1aea99ce9f9a">
<td align="left" valign="top">Endometrial cancer</td>
<td align="center" valign="middle">0.83 (0.47 to 1.47)</td>
<td align="center" valign="middle">6</td>
<td align="center" valign="middle">5</td>
</tr>
<tr id="id_6587d673-5bfb-498f-be7f-b70a32f6a18f">
<td align="left" valign="top">Hip fracture</td>
<td align="center" valign="middle">0.66 (0.45 to 0.98)</td>
<td align="center" valign="middle">15</td>
<td align="center" valign="middle">10</td>
</tr>
<tr id="id_2fe73033-4e0b-4883-8d68-4e04ffb56501">
<td align="left" valign="top">Death due to causes other than the events above</td>
<td align="center" valign="middle">0.92 (0.74 to 1.14)</td>
<td align="center" valign="middle">40</td>
<td align="center" valign="middle">37</td>
</tr>
<tr id="id_f5955a5a-082a-45b8-a8af-82c9d1aa39ce">
<td align="left" valign="top">Global Index<footnoteref idref="id-4c341f78-1dee-4e43-945e-eed8f00c090e"></footnoteref>
</td>
<td align="center" valign="middle">1.15 (1.03 to 1.28)</td>
<td align="center" valign="middle">151</td>
<td align="center" valign="middle">170</td>
</tr>
<tr id="id_5f7f5ada-2fd5-444c-a473-fd122a53051e">
<td align="left" valign="top">Deep vein thrombosis<footnote id="id-a2f0ba51-c342-421f-ad67-6608b5a7f60d">not included in Global Index<br/>
</footnote>
</td>
<td align="center" valign="middle">2.07 (1.49 to 2.87)</td>
<td align="center" valign="middle">13</td>
<td align="center" valign="middle">26</td>
</tr>
<tr id="id_c6f2e323-e48e-4204-91cc-1c8aae67c21f">
<td align="left" valign="top">Vertebral fractures<footnoteref idref="id-a2f0ba51-c342-421f-ad67-6608b5a7f60d"></footnoteref>
</td>
<td align="center" valign="middle">0.66 (0.44 to 0.98)</td>
<td align="center" valign="middle">15</td>
<td align="center" valign="middle">9</td>
</tr>
<tr id="id_023123a4-fe23-4797-a272-82b403fd304e" stylecode="Botrule">
<td align="left" valign="top">Other osteoporotic fractures<footnoteref idref="id-a2f0ba51-c342-421f-ad67-6608b5a7f60d"></footnoteref>
</td>
<td align="center" valign="middle">0.77 (0.69 to 0.86)</td>
<td align="center" valign="middle">170</td>
<td align="center" valign="middle">131</td>
</tr>
</tbody>
</table>